George Nomikos - 01 Nov 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Chief Medical Officer
Signature
/s/ George Nomikos
Issuer symbol
LPCN
Transactions as of
01 Nov 2022
Transactions value $
$50,750
Form type
4
Filing time
08 Nov 2022, 10:57:25 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $50,750 +125,000 $0.4060 125,000 01 Nov 2022 Common Stock 125,000 $0.4060 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of November 1, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.